{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:30:11Z","timestamp":1790497811722,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1097\/mpa.0000000000000843","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T14:29:28Z","timestamp":1497364168000},"page":"813-819","source":"Crossref","is-referenced-by-count":40,"title":["Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Kristina L.","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Delitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Behrns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Trevino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210212","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"R2-16-20210212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R4-16-20210212","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J Clin Oncol"},{"key":"R5-16-20210212","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R6-16-20210212","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","article-title":"An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status","volume":"67","author":"Sun","year":"2015","journal-title":"Nutr Cancer"},{"key":"R7-16-20210212","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R8-16-20210212","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R9-16-20210212","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-16-20210212","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ajpath.2015.01.016","article-title":"Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements","volume":"185","author":"Delitto","year":"2015","journal-title":"Am J Pathol"},{"key":"R11-16-20210212","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.3748\/wjg.v18.i22.2867","article-title":"Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts","volume":"18","author":"Jiang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R12-16-20210212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13058-015-0523-1","article-title":"Patient-derived xenograft models of breast cancer and their predictive power","volume":"17","author":"Whittle","year":"2015","journal-title":"Breast Cancer Res"},{"key":"R13-16-20210212","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrc3972","article-title":"Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts","volume":"15","author":"Hoffman","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R14-16-20210212","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"key":"R15-16-20210212","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1245\/s10434-014-4241-1","article-title":"The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma","volume":"22","author":"Thomas","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R16-16-20210212","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","article-title":"A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens","volume":"89","author":"Fu","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-16-20210212","first-page":"3070","article-title":"A novel \u201cpatient-like\u201d treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice","volume":"53","author":"Furukawa","year":"1993","journal-title":"Cancer Res"},{"key":"R18-16-20210212","doi-asserted-by":"crossref","first-page":"e114310","DOI":"10.1371\/journal.pone.0114310","article-title":"Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore","volume":"9","author":"Hiroshima","year":"2014","journal-title":"PLoS One"},{"key":"R19-16-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pan.2015.02.008","article-title":"Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC)","volume":"15","author":"Hiroshima","year":"2015","journal-title":"Pancreatology"},{"key":"R20-16-20210212","doi-asserted-by":"crossref","first-page":"12346","DOI":"10.18632\/oncotarget.2641","article-title":"Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models","volume":"5","author":"Hiroshima","year":"2014","journal-title":"Oncotarget"},{"key":"R21-16-20210212","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jcb.24769","article-title":"Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX)","volume":"115","author":"Hiroshima","year":"2014","journal-title":"J Cell Biochem"},{"key":"R22-16-20210212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jso.23816","article-title":"Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer","volume":"111","author":"Hiroshima","year":"2015","journal-title":"J Surg Oncol"},{"key":"R23-16-20210212","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/jcb.24099","article-title":"Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens","volume":"113","author":"Suetsugu","year":"2012","journal-title":"J Cell Biochem"},{"key":"R24-16-20210212","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.138.11.3873","article-title":"The composition of the T cell receptor repertoire in nude mice","volume":"138","author":"Maleckar","year":"1987","journal-title":"J Immunol"},{"key":"R25-16-20210212","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1126\/science.183.4124.534","article-title":"Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice","volume":"183","author":"Stutman","year":"1974","journal-title":"Science"},{"key":"R26-16-20210212","first-page":"353","article-title":"Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous matings and heterozygous matings and effect of age and carcinogen dose","volume":"62","author":"Stutman","year":"1979","journal-title":"J Natl Cancer Inst"},{"key":"R27-16-20210212","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"R28-16-20210212","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/ijc.23772","article-title":"Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD\/scid-related strains","volume":"123","author":"Agliano","year":"2008","journal-title":"Int J Cancer"},{"key":"R29-16-20210212","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol"},{"key":"R30-16-20210212","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R31-16-20210212","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nm.2454","article-title":"Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes","volume":"17","author":"DeRose","year":"2011","journal-title":"Nat Med"},{"key":"R32-16-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/2326-6066.CIR-16-0045","article-title":"De-risking immunotherapy: report of a consensus workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute","volume":"4","author":"Mellman","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"R33-16-20210212","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/onc.2015.94","article-title":"XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer","volume":"35","author":"Morton","year":"2016","journal-title":"Oncogene"},{"key":"R34-16-20210212","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2015.09.001","article-title":"Transplantation of human spleen into immunodeficient NOD\/SCID IL2Rgamma(null) mice generates humanized mice that improve functional B cell development","volume":"161","author":"Chung","year":"2015","journal-title":"Clin Immunol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:00:37Z","timestamp":1692838837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201707000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000843","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}